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Abstract
There is an accumulating amount of evidence indicating that lipid oxidation is depressed in the
skeletal muscle of obese individuals. Decrements in fatty acid oxidation (FAO) have been reported
with obesity in models ranging from whole body measurements to isolated skeletal muscle
preparations as well as in myotubes raised in culture. This reduction appears to be associated with a
depression in the activities of enzymes involved in various steps of lipid oxidation, which
subsequently partitions lipid entering the cell toward storage. The defect in FAO in skeletal muscle
may be critical in relation to health, as a reduction in the capacity for lipid oxidation could directly
or indirectly contribute to the insulin resistance commonly evident with obesity. Although less
characterized, a decrement in FAO has also been linked with weight gain, which suggests that this
characteristic may be an integral aspect leading to the obese state. In terms of intervention, weight
loss does not seem to correct the defect in FAO with obesity. This review will provide evidence
supporting a reduction in muscle FAO with obesity.
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THE PREVALENCE OF OBESITY is increasing dramatically in the United States and other
industrialized nations (33,51). Obesity is associated with a variety of health-related risks, such
as coronary heart disease, hypertension, and type 2 diabetes, all of which may center around
insulin resistance (i.e., the metabolic syndrome) (39). It is thus essential to identify
characteristics that predispose individuals toward obesity or negative conditions that occur
during the development of the obese state, which subsequently alter metabolism and health
status in a negative manner.
Skeletal muscle is a metabolically active tissue that is critical to maintaining whole body
homeostasis due to its energy needs as well as its relatively large mass. In terms of carbohydrate
metabolism, a major portion of an ingested glucose load is either stored as glycogen or oxidized
in skeletal muscle (14). Skeletal muscle also plays an important role in fatty acid oxidation
(FAO). During the fasted state, FAO is the predominant metabolic activity of skeletal muscle
(13,51). At rest, the oxidation of lipid contributes significantly to overall energy needs with
most of the energy requirements of muscle being obtained via FAO (10,13). Such data indicates
that skeletal muscle is quantitatively important in relation to the fate of lipid. Factors that elicit
a decrement in the ability to oxidize lipid in skeletal muscle would thus be anticipated to evoke
profound changes in whole body homeostasis. The intent of this paper is to review some of the
evidence indicating a decrement in skeletal muscle lipid oxidation with obesity.
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Is There a Decrement in Fat Oxidation with Obesity?
Determining the mechanisms that are linked with obesity is problematic in that when studying
the obese individual, it is difficult to discern whether the findings obtained are due to 1) an
inherent predisposition to obesity, 2) conditions that developed during years of gaining body
mass from positive energy balance, or 3) both. In relation to the ability to utilize lipid, there
are limited prospective data indicating that a propensity for weight gain is associated with
substrate utilization, which favors carbohydrate over lipid oxidation. When discussing whole
body substrate utilization the terms respiratory quotient (RQ) and respiratory exchange ration
(RER) are used interchangeably; regardless of terminology a higher RQ-RER is indicative of
a reduced capacity to oxidize lipid. In nondiabetic Pima Indians, Zurlo et al. (54) reported a
familial influence on RQ and that a low capacity for fat oxidation was associated with an
increased risk for weight gain. Similar findings were obtained by Marra et al. (31) who reported
that a higher whole body RQ predicted weight gain in lean women. Other work has supported
the premise that an elevated whole body RQ-RER is predictive of weight gain in both lean and
obese individuals (32,43), although this is not always the case (25). While these findings are
somewhat sparse, the data suggests that weight gain is linked with an inability to utilize lipid
as measured at the whole body level.
Another experimental method for discerning mechanisms potentially linked with obesity is to
examine obese subjects after weight loss. This approach theoretically provides a glimpse of
the “preobese” state, as it has already been demonstrated that the subjects have a propensity
toward obesity. A weight loss model that our laboratory has utilized is studying extremely
obese subjects (body mass index ≥ 40 kg/m2) before and ~1 yr or longer after gastric bypass
surgery (36). This intervention induces a long-term weight loss of ~50 kg with patients
becoming weight stable at ~12 mo after the surgery (36); subjects are thus tested in a relatively
stable condition when confounding factors, such as energy imbalance, are minimized. Using
this model, we observed that previously extremely obese women of mixed ethnicities after
weight loss still exhibited a preference for carbohydrate over fat oxidation compared with
weight-matched individuals who were never extremely obese; substrate utilization was
determined at the whole body level with indirect calorimetry during submaximal exercise
(17). This observation was supported by tracking the oxidation of [13C] palmitate at rest and
during submaximal exercise in lean, extremely obese, and extremely obese women after weight
loss (48). The relative percentage of fat oxidation was similar in both the extremely obese and
extremely obese women after weight loss and significantly reduced compared with the lean
subjects (Fig. 1); these findings suggest that a reduced capacity for lipid oxidation is linked
with a propensity toward extreme obesity.
Other studies have examined the effect of weight loss on substrate utilization in obese
individuals at the whole body level and obtained similar results. Larson et al. (30) studied
previously obese individuals who lost a mean of 57 kg via energy restriction and found that
fat oxidation (as determined with indirect calorimetry) was significantly depressed in the
weight-loss (postobese) group compared with weight-matched controls. Similarly, Kelley et
al. (26) reported no change in resting RQ when determining substrate utilization across a
skeletal muscle bed in the legs of obese individuals before and after weight loss. In postobese
individuals, a decrement in fat oxidation during submaximal exercise as well as at rest has also
been found (for reviews, see Ref. 4–6).
Another approach to discerning whether there is a defect in fat oxidation with obesity at the
whole body level has been to examine the responses to dietary lipid in obese or obese
individuals after weight loss. Although the mechanistic link between a reduced capacity for
fat oxidation and obesity has not been characterized, one possibility is that an inability to
increase fat oxidation when faced with the consumption of dietary fat contributes to positive
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fat balance, the accumulation of adipose tissue, and eventually weight gain and obesity (16,
38). In support of this hypothesis, obese individuals displayed an impaired capacity to oxidize
lipid in response to an increase in dietary fat compared with lean subjects (7,16,41). Individuals
examined after weight loss also failed to increase the ratio of fat to carbohydrate oxidation
when exposed to a high-fat diet that resulted in positive fat balance (1). Together, these findings
imply that a reduced capacity for fat oxidation is evident at the whole body level with obesity.
There are conflicting data, however, which indicate either no difference (46,47,50) or an
elevated (15,21,24) rate of lipid oxidation in obese compared with lean individuals. An
explanation for this disparity may involve factors such as the degree of adiposity in the subjects
examined, gender differences, nutritive status during the measurement of lipid oxidation (i.e.,
fasting or insulin-stimulated), how whole body fatty acid oxidation is expressed (i.e., per
kilogram of body or fat mass), and, in exercise studies, the intensity of the workload selected
(48); however, it is difficult to definitively explain why these differences exist between studies.
The intent of the current review is to present and summarize findings indicating lipid oxidation
in skeletal muscle is impaired with obesity and allow the reader to use these data to formulate
their own hypotheses.
Is There a Decrement in the Ability of Skeletal Muscle to Oxidize Lipid with
Obesity?
The whole body measurements discussed above are indicative of a decrement in FAO with
obesity, which implies at least a partial involvement of skeletal muscle; in support, direct
measurements made in this tissue indicate a decrement in the ability to oxidize lipid. In our
laboratory we have observed a reduction in FAO in the skeletal muscle of extremely obese
individuals under several different experimental conditions. In one of our first studies, muscle
strip preparations were obtained from the rectus abdominus of lean, obese, and extremely obese
individuals and incubated with labeled palmitate (22). In muscle strips from extremely obese
individuals there was a significant decrease in FAO and increased partitioning of lipid toward
storage (22). The finding of a reduction in FAO with obesity was validated in a subsequent
study of another muscle group, the vastus lateralis, by obtaining needle biopsies from lean and
extremely obese individuals and measuring labeled palmitate oxidation in muscle homogenates
(28). The integration of these findings (22,28) provides relatively convincing evidence for a
reduction in FAO in the skeletal muscle of extremely obese individuals, as FAO was reduced
in two separate muscle groups in different anatomical areas. Validation in distinct muscle
groups is critical as skeletal muscle is a heterogeneous tissue that can vary widely in respect
to fiber composition and contractile activity.
Another approach to study metabolism in skeletal muscle is the use of primary cell cultures.
Briefly, this method involves isolating satellite cells from a muscle biopsy and treating the
cells so that they proliferate into myoblasts and ultimately differentiate into myotubes (3). The
myotubes possess many of the qualities of intact muscle fibers and are suitable for examining
substrate utilization. Using this human skeletal muscle cell culture method (HSkMC), we
compared the capacity for lipid oxidation in cells derived from lean and extremely obese donors
and observed that FAO (measured with [l-14C] palmitate) was depressed in cells from obese
subjects (23). The magnitude of the decrement in FAO was similar to our in vivo (17,48) and
in vitro (22,28) findings comparing lean and extremely obese individuals (Fig. 2). The HSkMC
technique involves culturing the cells ex vivo for ~4–6 wk; under these conditions it is believed
that any expressed phenotype is largely the result of genetic or epigenetic origins (3). If this is
the case, our HSkMC data (23) implies that extremely obese individuals may have a
predisposition toward a reduction in FAO in skeletal muscle. Another study reported that the
ability to oxidize lipid in response to an increased lipid load in HSkMC mirrored metabolic
traits determined in vivo in lean individuals, indicating the potential utility of HSkMC in
studying lipid oxidation (49).
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Other work has indicated a defect in FAO specific to skeletal muscle with obesity. Colberg et
al. (11) examined the ability of skeletal muscle to utilize free fatty acids (FFA) with the leg
balance technique in lean and obese premenopausal women. These authors (11) reported that
women with visceral obesity had a reduced rate of FFA uptake and oxidation in muscle under
fasting conditions. Using similar methodology (leg balance), this group confirmed their earlier
findings by reporting an elevated leg RQ in obese subjects (26). Utilizing an in vitro muscle
preparation, Kirkwood et al. (29) reported a statistically significant and negative relationship
between maximally stimulated muscle respiration and body fat content.
The reduction in FAO in the skeletal muscle of obese individuals may be linked, at least in
part, with a decreased activity of enzymes involved in lipid oxidation. Although enzymatic
activities or protein content may not necessarily reflect substrate flux, Simoneau et al. (45)
reported that the activities of carnitine palmitoyl transferase (CPT-1), citrate synthase (CS),
and cytochrome c oxidase were significantly depressed in skeletal muscle samples (vastus
lateralis) obtained from obese compared with lean subjects. These data are significant in that
they suggest defects at several key regulatory steps in FAO, such as lipid transfer into the
mitochondria (CPT-1), the Krebs cycle (CS), and the electron transport system (cytochrome
c oxidase). Several studies have confirmed reductions in CPT-1, CS, and cytochrome c oxidase
in the skeletal muscle of obese individuals (19,26,28); similarly, others (27,40) have reported
a reduction in the activity of the respiratory chain in skeletal muscle from obese individuals.
Ratios of enzyme activities indicative of glycolytic to oxidative flux, such as glycogen
phosphorylase to CS (44) and lipid oxidation to lipid transfer (CPT-1 to fatty acid binding
protein) (45) are also supportive of a reduced capacity for lipid oxidation in skeletal muscle
with obesity. Zurlo et al. (55) reported a negative relationship between 24-h RQ and (β-
hydroxyacl-coenzyme A dehydrogenase activity, which implies that variability exists in the
process of β-oxidation, which may influence the capacity for FAO. In support of a defect in
β-oxidation, we reported a reduction in (β-hydroxyacl-coenzyme A dehydrogenase activity in
the skeletal muscle of extremely obese individuals (28). Together, these data provide evidence
for a reduction in the activities of key oxidative enzymes involved in FAO in the skeletal muscle
of obese individuals, which is unfortunately not corrected with weight loss (26,45). While the
mechanism(s) responsible for the depression in enzyme activity is not evident, peroxisome-
proliferator-activated receptor-γ coactivator-1α, which is an important regulator of
mitochondrial biogenesis, has been reported to be lower in the skeletal muscle of obese, insulin-
resistant subjects compared with lean controls (19).
In addition to reductions in enzyme activities linked with FAO, there are also alterations in
mitochondrial morphology with obesity. Kirwood et al. (29) demonstrated that the central
distribution of body fat was associated with a lower mitochondrial density, as determined by
electron microscopy. Other work using electron microscopy (27) indicated that skeletal muscle
mitochondria were smaller by ~35% in type 2 diabetic and obese subjects compared with lean
subjects. The mitoschondria from the obese and diabetic subjects also had a less well-defined
inner membrane structure, including a narrower cristae (27). Similar alterations in
mitochondrial morphology, such as reduced size, are evident in myopathies in which the
function of this organelle is compromised (52). There may also be an alteration in the
distribution of mitochondria within the skeletal muscle of obese individuals, as the number of
subsarcolemmal mitochondria has been reported to be reduced with obesity and type 2 diabetes
along with decreased electron transport chain activity (40). It is believed that one of the primary
duties of subsarcolemmal mitochondria is to oxidize lipid (20), the reduction of mass in this
fraction coupled with reduced enzymatic activity per unit of mitochondria with obesity (40)
may provide an underlying mechanism for the decrement in FAO.
While the above findings indicate a defect in oxidative processes, there also appears to be a
congruent increase in the capacity for lipid storage in the skeletal muscle of obese individuals,
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which would contribute to an accumulation of intramuscular lipid. For example, Simoneau et
al. (45) reported elevated levels of fatty acid binding protein in the plasma membrane fraction
of muscle from obese individuals. Bonen et al. (8) studied giant sarcolemmal vesicles prepared
from skeletal muscle biopsies and reported that long-chain fatty acid transport into skeletal
muscle was upregulated by approximately fourfold with obesity. This increase in fatty acid
transport was associated with an elevated level of FAT/CD36 (fatty acid translocase) in the
sarcolemmal fraction (8). Hulver et al. (23) reported that stearoyl-CoA desaturase-1, a
lipogenic gene, was robustly upregulated in the skeletal muscle of extremely obese individuals
and that this characteristic was retained in culture (HSkMC). Overexpression of stearoyl-CoA
desaturase-1 in myotubes from lean subjects increased fatty acid esterification and depressed
FAO, suggesting a potential duel regulation of lipid-handling pathways by stearoyl-CoA
desaturase-1. Together, the findings of a depression in FAO coupled with an increased capacity
for lipogenesis indicates a global organization of lipid metabolism in obese skeletal muscle
that is biased toward storage and esterification (Fig. 3).
Some insight into the mechanisms responsible for the decrement in FAO in skeletal muscle
with obesity may be obtained by studying the effects of interventions. Weight loss does not
seem to alter fat oxidation in the skeletal muscle of obese individuals (17,26,30,45,48). On the
other hand, contractile activity, i.e., physical activity or exercise training has been reported to
enhance the capacity for lipid oxidation in the skeletal muscle of obese subjects. We observed
that a short-term endurance-oriented training model, which did not induce weight loss (10
consecutive days, 60 min/day at 75% V̇o2peak) improved fatty acid oxidation in the skeletal
muscle of morbidly obese individuals (2). Menshikova et al. (33) reported that in obese
individuals moderate physical activity combined with weight loss increased oxidative enzyme
activities without a significant increase in mitochondrial DNA, although there was evidence
for an increase in mitochondrial cristae. This pattern differs from the classical mitochondrial
biogenesis seen with physical activity in lean individuals (33). Together, these findings suggest
that some aspect linked with contractile activity either directly overcomes or somehow
compensates for the decrement in FAO seen in the skeletal muscle of obese individuals. The
exact mechanism(s) responsible, however, remain to be discerned.
Possible Interactions Between Fatty Acid Oxidation and Insulin Action with
Obesity
A health concern with obesity is the presence of insulin resistance. The coexistence of insulin
resistance, intramuscular lipid accumulation, and a decrement in FAO in skeletal muscle are
often simultaneously evident in obese individuals (for reviews, see Refs. 4,6,35). However,
the mechanistic link between FAO and insulin resistance in the skeletal muscle of obese
individuals is not yet apparent.
There is evidence suggesting that the accumulation of lipid within the skeletal muscle of obese
individuals induces insulin resistance. Several studies suggest that fatty-acid-derived
metabolites, such as long-chain acyl CoA, diacylglycerol, and ceramide accumulate in the
cytosol of the skeletal muscle of obese individuals. These intermediates then either directly or
indirectly impair insulin signal transduction and/or the activity of enzymes involved in glucose
utilization, which in turn induces insulin resistance (for reviews, see Refs. 12,18,36). The
accumulation of these metabolically active lipid intermediates could be due, at least in part, to
the disturbances in mitochondrial function and depression in FAO that may occur with obesity.
There are also findings that suggest the capacity for FAO alone controls insulin action in
skeletal muscle. When overexpressing CPT1 in L6 myotubes, Perdomo et al. (35) reported an
increase in palmitate and oleate oxidation, which provided a protective effect against fatty-
acid-induced insulin resistance. The intriguing finding of this study (35) was that CPT1
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overexpression improved insulin action, despite no decrease in intracellular diacylglycerol,
long-chain acyl CoA, or ceramide, compared with lipid-treated control cells that were insulin
resistant; this observation prompted the hypothesis that accelerating FAO exerts an insulin-
sensitizing effect that functions independently of changes in cytosolic lipid content. In support,
in vivo human findings indicate that the oxidative capacity of skeletal muscle is an effective
predictor of whole body insulin action (9). However, other work utilizing HSkMC reported
that CPT1 overexpression was protective against the accumulation of diacylglycerol, ceramide,
and insulin resistance (42). While the cellular mechanism(s) responsible for lipid-induced
insulin resistance remain to be discerned, the findings remain supportive of the integral role
that FAO in skeletal muscle plays in controlling insulin action.
Perspectives and Significance
There is accumulating evidence indicating a defect in the capacity for FAO in the skeletal
muscle of obese individuals. The broad implications of this finding is that such a defect may
contribute to 1) the insulin resistance often evident with obesity and 2) the weight gain inherent
with the obese state. The mechanisms linking the obesity-associated reduction in lipid
oxidation with insulin-resistance and weight gain may be a fruitful area for future studies. For
example, it is not evident why the skeletal muscle of obese individuals exhibits a depression
in the activities of enzymes involved in various steps of lipid oxidation and how this alteration
contributes to the partitioning of lipid entering the cell toward storage. It is also not apparent
how interventions, such as physical activity, overcome or somehow compensate for the
decrement in FAO seen in the skeletal muscle of obese individuals. In conclusion, a reduction
in the capacity for lipid oxidation in the skeletal muscle of obese individuals may be an integral
component of the obese state.
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Percentage of plasma free fatty acid (FFA) uptake oxidized during basal and exercise (50%
maximum O2 consumption). *Significantly decreased in extremely obese and extremely obese
subjects after weight reduction (weight-reduced) compared with lean (P < 0.05). From Thyfault
et al. (48).
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Decrement in fatty acid oxidation (FAO) with obesity as indicated by various methodologies
used in our laboratory. Data are redrawn from Refs. 17,22,23,28,48. *Significantly different
(P ≤ 0.05) from lean controls for the listed method.
Houmard Page 11














Fatty acid partitioning [labeled oleate incorporation into triacylglycerol (TAG) divided by
FAO] in myotubes cultured from skeletal muscle samples obtained from lean and obese donors
(23). An increased fatty acid partitioning ratio indicates preferential portioning toward storage
within the muscle cell as opposed to oxidation. The positive relationship between the FAO
partitioning index of the myotubes and the body mass index of the donor was statistically
significant (r2 = 0.66, P < 0.001). HSkMC, human skeletal muscle cell culture method.
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